Novo Nordisk A/S

Novo Nordisk A/S is a leading global healthcare company headquartered in Bagsværd, Denmark, with over a century of innovation in service of defeating serious chronic diseases. Founded in 1923, the company is the world's largest producer of insulin and a pioneer in treatments for diabetes, obesity, rare blood disorders, and endocrine diseases. With a workforce of more than 69,000 employees operating in 80 offices worldwide, Novo Nordisk markets its life-changing pharmaceutical products in 170 countries. The organization is uniquely owned by the Novo Nordisk Foundation, ensuring a long-term commitment to scientific breakthroughs, environmental sustainability, and expanding global access to essential medicines.